Pitching at the Merck Innovation Challenge
Many of you know my drive to co-found Calla Lily Clinical Care was driven by my personal journey as a infertility survivor. The memory that remains particularly vivid is the distress caused by the inadequate methods of administering progesterone— whether through injections, pessaries, tablets, or suppositories. Each option (including now rings) has its pros and …
Callavid to be featured at PODD Conference
Excited to announce that Calla Lily Clinical Care will be attending the PODD Conference in Boston next week! Our Principal Scientist Andrew Lewis and co-founder Lara Zibners will be showcasing our innovative vaginal drug delivery platform and its numerous applications beginning with pregnancy and fertility, and exploring new partnership opportunities. Stay tuned for updates on …
Returning to Stanford University / Stanford d.school
I’m thrilled to be heading back to Stanford University and The Stanford d.school for the first time since graduating! I’ll be in the Bay Area next week from October 21st, representing Calla Lily Clinical Care 🌸. I’m excited to reconnect with professors, industry leaders, and former collegues on our exciting Callavid and Phlovid progress. I’d …
Top 6 Takeaways from the Women’s Health Innovation Summit in Boston
I feel like Boston is the place to be these days! I made my 3rd trip there in the last year to attend the Women’s Health Innovation Summit in Boston thanks to Kisaco Research and it was inspiring, to say the least. The event assembled leaders, innovators, and passionate professionals all focused on one mission: …
Calla Lily at CPHI Milan
We had an exciting & intense three days at CPHI Milan, connecting with business leaders from across the global life sciences industry, especially those passionate about advancing Womens Health. It was a pleasure to meet with our existing partners in person and explore exciting new materials and suppliers. We also uncovered unique opportunities for collaboration …
Visit to MIT Center for Gynepathology Research
I had the great honour of meeting with Linda Griffith, Professor of Biological and Mechanical Engineering, and MacVicar Fellow at Massachusetts Institute of Technology, where she leads the MIT Center for Gynepathology Research. I’ve long been inspired by Professor Griffith’s groundbreaking work, and now, with our progress and dedicated team & lab resources in place, …
Attending Tommy’s Preterm Birth Policy Lab
It has been an absolute pleasure and privilege participating at the Tommy’s Preterm Birth Policy Lab today hosted by Prof Catherine Williamson and Prof Anna David, moderated by Ross Pow (perfectly on schedule!). Experts from so many disciplines expressed their hopes and highlighted the obstacles on the road towards a real change in preventing PTB. …
Visit to Cambridge Design Partnership
We’ve made great strides in bringing in-house the R&D expertise and facilities needed to advance our vaginal drug delivery system. However, external partnerships remain key to achieving our ambitious goals. Our recent visit to Cambridge Design Partnership was a productive opportunity to align on our latest strategy and critical milestones, particularly around GMP manufacturing and …
“Unlocking the Potential of the Vaginal Microbiome” panel at WHIS Boston
Our Co-Founder Dr Lara Zibners will be at the Women’s Health Innovation USA 2024 summit in Boston to talk about the exciting vaginal microbiome space as part of the panel “Unlocking the Potential of the Vaginal Microbiome”. The advancing science is becoming impossible to ignore: reproductive tract dysbiosis or the lack of a healthy vaginal …
Dr. Emma Parry Joins as a Zinc NIHR Innovation Fellow
We’re delighted to welcome Dr. Emma Parry to our team as a Zinc NIHR Innovation Fellow! Emma brings invaluable expertise from her role as a clinical GP in Birmingham and as an academic GP at Royal Wolverhampton Hospitals NHS Trust. As we continue developing our patient-centric vaginal drug delivery system, Emma will play a key …